nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—NR3C1—hematologic cancer	0.0754	1	CbGaD
Fluocinolone Acetonide—Corticosteroid Hormone Receptor Agonists—Dexamethasone—hematologic cancer	0.0683	0.209	CiPCiCtD
Fluocinolone Acetonide—Corticosteroid Hormone Receptor Agonists—Betamethasone—hematologic cancer	0.0683	0.209	CiPCiCtD
Fluocinolone Acetonide—Corticosteroid Hormone Receptor Agonists—Triamcinolone—hematologic cancer	0.0659	0.202	CiPCiCtD
Fluocinolone Acetonide—Corticosteroid Hormone Receptor Agonists—Prednisolone—hematologic cancer	0.0638	0.195	CiPCiCtD
Fluocinolone Acetonide—Corticosteroid Hormone Receptor Agonists—Prednisone—hematologic cancer	0.0603	0.185	CiPCiCtD
Fluocinolone Acetonide—Dexamethasone—hematologic cancer	0.0578	0.258	CrCtD
Fluocinolone Acetonide—Betamethasone—hematologic cancer	0.0578	0.258	CrCtD
Fluocinolone Acetonide—Triamcinolone—hematologic cancer	0.0564	0.252	CrCtD
Fluocinolone Acetonide—Prednisolone—hematologic cancer	0.0523	0.233	CrCtD
Fluocinolone Acetonide—PLA2G4A—Epirubicin—hematologic cancer	0.0311	0.258	CbGbCtD
Fluocinolone Acetonide—SERPINA6—Triamcinolone—hematologic cancer	0.024	0.199	CbGbCtD
Fluocinolone Acetonide—SERPINA6—Prednisolone—hematologic cancer	0.0203	0.169	CbGbCtD
Fluocinolone Acetonide—NR3C1—Triamcinolone—hematologic cancer	0.0112	0.0932	CbGbCtD
Fluocinolone Acetonide—NR3C1—Betamethasone—hematologic cancer	0.00962	0.08	CbGbCtD
Fluocinolone Acetonide—NR3C1—Prednisolone—hematologic cancer	0.00949	0.0789	CbGbCtD
Fluocinolone Acetonide—NR3C1—Prednisone—hematologic cancer	0.00896	0.0745	CbGbCtD
Fluocinolone Acetonide—NR3C1—Dexamethasone—hematologic cancer	0.0056	0.0465	CbGbCtD
Fluocinolone Acetonide—Fluticasone furoate—Dexamethasone—hematologic cancer	0.00189	0.0111	CrCrCtD
Fluocinolone Acetonide—Fluticasone furoate—Betamethasone—hematologic cancer	0.00189	0.0111	CrCrCtD
Fluocinolone Acetonide—Fluticasone furoate—Triamcinolone—hematologic cancer	0.00184	0.0108	CrCrCtD
Fluocinolone Acetonide—Flurandrenolide—Betamethasone—hematologic cancer	0.00175	0.0103	CrCrCtD
Fluocinolone Acetonide—Flurandrenolide—Dexamethasone—hematologic cancer	0.00175	0.0103	CrCrCtD
Fluocinolone Acetonide—Flumethasone Pivalate—Betamethasone—hematologic cancer	0.0017	0.00996	CrCrCtD
Fluocinolone Acetonide—Flumethasone Pivalate—Dexamethasone—hematologic cancer	0.0017	0.00996	CrCrCtD
Fluocinolone Acetonide—Flumethasone Pivalate—Triamcinolone—hematologic cancer	0.00166	0.00973	CrCrCtD
Fluocinolone Acetonide—Difluprednate—Betamethasone—hematologic cancer	0.00164	0.00964	CrCrCtD
Fluocinolone Acetonide—Difluprednate—Dexamethasone—hematologic cancer	0.00164	0.00964	CrCrCtD
Fluocinolone Acetonide—Halobetasol Propionate—Dexamethasone—hematologic cancer	0.00164	0.00964	CrCrCtD
Fluocinolone Acetonide—Halobetasol Propionate—Betamethasone—hematologic cancer	0.00164	0.00964	CrCrCtD
Fluocinolone Acetonide—Fluticasone Propionate—Betamethasone—hematologic cancer	0.00164	0.00964	CrCrCtD
Fluocinolone Acetonide—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.00164	0.00964	CrCrCtD
Fluocinolone Acetonide—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.0016	0.00942	CrCrCtD
Fluocinolone Acetonide—Difluprednate—Triamcinolone—hematologic cancer	0.0016	0.00942	CrCrCtD
Fluocinolone Acetonide—Halobetasol Propionate—Triamcinolone—hematologic cancer	0.0016	0.00942	CrCrCtD
Fluocinolone Acetonide—Flurandrenolide—Prednisolone—hematologic cancer	0.00159	0.00933	CrCrCtD
Fluocinolone Acetonide—Fluocinonide—Dexamethasone—hematologic cancer	0.00154	0.00906	CrCrCtD
Fluocinolone Acetonide—Fluocinonide—Betamethasone—hematologic cancer	0.00154	0.00906	CrCrCtD
Fluocinolone Acetonide—Clocortolone—Betamethasone—hematologic cancer	0.00154	0.00906	CrCrCtD
Fluocinolone Acetonide—Clocortolone—Dexamethasone—hematologic cancer	0.00154	0.00906	CrCrCtD
Fluocinolone Acetonide—Beclomethasone—Betamethasone—hematologic cancer	0.00154	0.00906	CrCrCtD
Fluocinolone Acetonide—Beclomethasone—Dexamethasone—hematologic cancer	0.00154	0.00906	CrCrCtD
Fluocinolone Acetonide—Clocortolone—Triamcinolone—hematologic cancer	0.00151	0.00886	CrCrCtD
Fluocinolone Acetonide—Beclomethasone—Triamcinolone—hematologic cancer	0.00151	0.00886	CrCrCtD
Fluocinolone Acetonide—Fluocinonide—Triamcinolone—hematologic cancer	0.00151	0.00886	CrCrCtD
Fluocinolone Acetonide—Fluocortolone—Dexamethasone—hematologic cancer	0.0015	0.0088	CrCrCtD
Fluocinolone Acetonide—Fluocortolone—Betamethasone—hematologic cancer	0.0015	0.0088	CrCrCtD
Fluocinolone Acetonide—Fluocortolone—Triamcinolone—hematologic cancer	0.00146	0.0086	CrCrCtD
Fluocinolone Acetonide—Alclometasone—Dexamethasone—hematologic cancer	0.00146	0.00856	CrCrCtD
Fluocinolone Acetonide—Alclometasone—Betamethasone—hematologic cancer	0.00146	0.00856	CrCrCtD
Fluocinolone Acetonide—Alclometasone—Triamcinolone—hematologic cancer	0.00142	0.00836	CrCrCtD
Fluocinolone Acetonide—Budesonide—Betamethasone—hematologic cancer	0.00142	0.00833	CrCrCtD
Fluocinolone Acetonide—Amcinonide—Dexamethasone—hematologic cancer	0.00142	0.00833	CrCrCtD
Fluocinolone Acetonide—Budesonide—Dexamethasone—hematologic cancer	0.00142	0.00833	CrCrCtD
Fluocinolone Acetonide—Amcinonide—Betamethasone—hematologic cancer	0.00142	0.00833	CrCrCtD
Fluocinolone Acetonide—Clocortolone—Prednisolone—hematologic cancer	0.0014	0.0082	CrCrCtD
Fluocinolone Acetonide—Beclomethasone—Prednisolone—hematologic cancer	0.0014	0.0082	CrCrCtD
Fluocinolone Acetonide—Fluocortolone—Prednisone—hematologic cancer	0.00139	0.00816	CrCrCtD
Fluocinolone Acetonide—Amcinonide—Triamcinolone—hematologic cancer	0.00139	0.00814	CrCrCtD
Fluocinolone Acetonide—Budesonide—Triamcinolone—hematologic cancer	0.00139	0.00814	CrCrCtD
Fluocinolone Acetonide—Fludrocortisone—Betamethasone—hematologic cancer	0.00138	0.00812	CrCrCtD
Fluocinolone Acetonide—Clobetasol propionate—Betamethasone—hematologic cancer	0.00138	0.00812	CrCrCtD
Fluocinolone Acetonide—Clobetasol propionate—Dexamethasone—hematologic cancer	0.00138	0.00812	CrCrCtD
Fluocinolone Acetonide—Desonide—Dexamethasone—hematologic cancer	0.00138	0.00812	CrCrCtD
Fluocinolone Acetonide—Desonide—Betamethasone—hematologic cancer	0.00138	0.00812	CrCrCtD
Fluocinolone Acetonide—Diflorasone—Dexamethasone—hematologic cancer	0.00138	0.00812	CrCrCtD
Fluocinolone Acetonide—Flunisolide—Betamethasone—hematologic cancer	0.00138	0.00812	CrCrCtD
Fluocinolone Acetonide—Fludrocortisone—Dexamethasone—hematologic cancer	0.00138	0.00812	CrCrCtD
Fluocinolone Acetonide—Diflorasone—Betamethasone—hematologic cancer	0.00138	0.00812	CrCrCtD
Fluocinolone Acetonide—Flunisolide—Dexamethasone—hematologic cancer	0.00138	0.00812	CrCrCtD
Fluocinolone Acetonide—Fluocortolone—Prednisolone—hematologic cancer	0.00136	0.00797	CrCrCtD
Fluocinolone Acetonide—Alclometasone—Prednisone—hematologic cancer	0.00135	0.00794	CrCrCtD
Fluocinolone Acetonide—Flunisolide—Triamcinolone—hematologic cancer	0.00135	0.00793	CrCrCtD
Fluocinolone Acetonide—Diflorasone—Triamcinolone—hematologic cancer	0.00135	0.00793	CrCrCtD
Fluocinolone Acetonide—Fludrocortisone—Triamcinolone—hematologic cancer	0.00135	0.00793	CrCrCtD
Fluocinolone Acetonide—Clobetasol propionate—Triamcinolone—hematologic cancer	0.00135	0.00793	CrCrCtD
Fluocinolone Acetonide—Desonide—Triamcinolone—hematologic cancer	0.00135	0.00793	CrCrCtD
Fluocinolone Acetonide—Paramethasone—Betamethasone—hematologic cancer	0.00135	0.00791	CrCrCtD
Fluocinolone Acetonide—Paramethasone—Dexamethasone—hematologic cancer	0.00135	0.00791	CrCrCtD
Fluocinolone Acetonide—Alclometasone—Prednisolone—hematologic cancer	0.00132	0.00775	CrCrCtD
Fluocinolone Acetonide—Paramethasone—Triamcinolone—hematologic cancer	0.00132	0.00773	CrCrCtD
Fluocinolone Acetonide—Amcinonide—Prednisone—hematologic cancer	0.00132	0.00773	CrCrCtD
Fluocinolone Acetonide—Budesonide—Prednisone—hematologic cancer	0.00132	0.00773	CrCrCtD
Fluocinolone Acetonide—Desoximetasone—Dexamethasone—hematologic cancer	0.00131	0.00772	CrCrCtD
Fluocinolone Acetonide—Desoximetasone—Betamethasone—hematologic cancer	0.00131	0.00772	CrCrCtD
Fluocinolone Acetonide—Desoximetasone—Triamcinolone—hematologic cancer	0.00128	0.00754	CrCrCtD
Fluocinolone Acetonide—Budesonide—Prednisolone—hematologic cancer	0.00128	0.00754	CrCrCtD
Fluocinolone Acetonide—Amcinonide—Prednisolone—hematologic cancer	0.00128	0.00754	CrCrCtD
Fluocinolone Acetonide—Triamcinolone—Dexamethasone—hematologic cancer	0.00128	0.00754	CrCrCtD
Fluocinolone Acetonide—Triamcinolone—Betamethasone—hematologic cancer	0.00128	0.00754	CrCrCtD
Fluocinolone Acetonide—Mometasone—Betamethasone—hematologic cancer	0.00128	0.00754	CrCrCtD
Fluocinolone Acetonide—Fluprednidene Acetate—Dexamethasone—hematologic cancer	0.00128	0.00754	CrCrCtD
Fluocinolone Acetonide—Fluprednidene Acetate—Betamethasone—hematologic cancer	0.00128	0.00754	CrCrCtD
Fluocinolone Acetonide—Fluorometholone—Dexamethasone—hematologic cancer	0.00128	0.00754	CrCrCtD
Fluocinolone Acetonide—Mometasone—Dexamethasone—hematologic cancer	0.00128	0.00754	CrCrCtD
Fluocinolone Acetonide—Fluorometholone—Betamethasone—hematologic cancer	0.00128	0.00754	CrCrCtD
Fluocinolone Acetonide—Diflorasone—Prednisone—hematologic cancer	0.00128	0.00753	CrCrCtD
Fluocinolone Acetonide—Flunisolide—Prednisone—hematologic cancer	0.00128	0.00753	CrCrCtD
Fluocinolone Acetonide—Desonide—Prednisone—hematologic cancer	0.00128	0.00753	CrCrCtD
Fluocinolone Acetonide—Clobetasol propionate—Prednisone—hematologic cancer	0.00128	0.00753	CrCrCtD
Fluocinolone Acetonide—Fludrocortisone—Prednisone—hematologic cancer	0.00128	0.00753	CrCrCtD
Fluocinolone Acetonide—Betamethasone—Dexamethasone—hematologic cancer	0.00125	0.00737	CrCrCtD
Fluocinolone Acetonide—Rimexolone—Betamethasone—hematologic cancer	0.00125	0.00737	CrCrCtD
Fluocinolone Acetonide—Dexamethasone—Betamethasone—hematologic cancer	0.00125	0.00737	CrCrCtD
Fluocinolone Acetonide—Rimexolone—Dexamethasone—hematologic cancer	0.00125	0.00737	CrCrCtD
Fluocinolone Acetonide—Fluorometholone—Triamcinolone—hematologic cancer	0.00125	0.00737	CrCrCtD
Fluocinolone Acetonide—Mometasone—Triamcinolone—hematologic cancer	0.00125	0.00737	CrCrCtD
Fluocinolone Acetonide—Fluprednidene Acetate—Triamcinolone—hematologic cancer	0.00125	0.00737	CrCrCtD
Fluocinolone Acetonide—Diflorasone—Prednisolone—hematologic cancer	0.00125	0.00735	CrCrCtD
Fluocinolone Acetonide—Fludrocortisone—Prednisolone—hematologic cancer	0.00125	0.00735	CrCrCtD
Fluocinolone Acetonide—Desonide—Prednisolone—hematologic cancer	0.00125	0.00735	CrCrCtD
Fluocinolone Acetonide—Clobetasol propionate—Prednisolone—hematologic cancer	0.00125	0.00735	CrCrCtD
Fluocinolone Acetonide—Flunisolide—Prednisolone—hematologic cancer	0.00125	0.00735	CrCrCtD
Fluocinolone Acetonide—Paramethasone—Prednisone—hematologic cancer	0.00125	0.00734	CrCrCtD
Fluocinolone Acetonide—Rimexolone—Triamcinolone—hematologic cancer	0.00123	0.0072	CrCrCtD
Fluocinolone Acetonide—Betamethasone—Triamcinolone—hematologic cancer	0.00123	0.0072	CrCrCtD
Fluocinolone Acetonide—Dexamethasone—Triamcinolone—hematologic cancer	0.00123	0.0072	CrCrCtD
Fluocinolone Acetonide—Paramethasone—Prednisolone—hematologic cancer	0.00122	0.00716	CrCrCtD
Fluocinolone Acetonide—Desoximetasone—Prednisone—hematologic cancer	0.00122	0.00716	CrCrCtD
Fluocinolone Acetonide—Methylprednisolone—Dexamethasone—hematologic cancer	0.0012	0.00705	CrCrCtD
Fluocinolone Acetonide—Methylprednisolone—Betamethasone—hematologic cancer	0.0012	0.00705	CrCrCtD
Fluocinolone Acetonide—Fluprednidene Acetate—Prednisone—hematologic cancer	0.00119	0.00699	CrCrCtD
Fluocinolone Acetonide—Mometasone—Prednisone—hematologic cancer	0.00119	0.00699	CrCrCtD
Fluocinolone Acetonide—Triamcinolone—Prednisone—hematologic cancer	0.00119	0.00699	CrCrCtD
Fluocinolone Acetonide—Fluorometholone—Prednisone—hematologic cancer	0.00119	0.00699	CrCrCtD
Fluocinolone Acetonide—Desoximetasone—Prednisolone—hematologic cancer	0.00119	0.00699	CrCrCtD
Fluocinolone Acetonide—Prednisolone—Betamethasone—hematologic cancer	0.00117	0.0069	CrCrCtD
Fluocinolone Acetonide—Prednisolone—Dexamethasone—hematologic cancer	0.00117	0.0069	CrCrCtD
Fluocinolone Acetonide—Methylprednisolone—Triamcinolone—hematologic cancer	0.00117	0.00688	CrCrCtD
Fluocinolone Acetonide—Dexamethasone—Prednisone—hematologic cancer	0.00116	0.00683	CrCrCtD
Fluocinolone Acetonide—Rimexolone—Prednisone—hematologic cancer	0.00116	0.00683	CrCrCtD
Fluocinolone Acetonide—Betamethasone—Prednisone—hematologic cancer	0.00116	0.00683	CrCrCtD
Fluocinolone Acetonide—Mometasone—Prednisolone—hematologic cancer	0.00116	0.00682	CrCrCtD
Fluocinolone Acetonide—Triamcinolone—Prednisolone—hematologic cancer	0.00116	0.00682	CrCrCtD
Fluocinolone Acetonide—Fluprednidene Acetate—Prednisolone—hematologic cancer	0.00116	0.00682	CrCrCtD
Fluocinolone Acetonide—Fluorometholone—Prednisolone—hematologic cancer	0.00116	0.00682	CrCrCtD
Fluocinolone Acetonide—Prednisolone—Triamcinolone—hematologic cancer	0.00115	0.00674	CrCrCtD
Fluocinolone Acetonide—Betamethasone—Prednisolone—hematologic cancer	0.00114	0.00667	CrCrCtD
Fluocinolone Acetonide—Dexamethasone—Prednisolone—hematologic cancer	0.00114	0.00667	CrCrCtD
Fluocinolone Acetonide—Rimexolone—Prednisolone—hematologic cancer	0.00114	0.00667	CrCrCtD
Fluocinolone Acetonide—Methylprednisolone—Prednisone—hematologic cancer	0.00111	0.00653	CrCrCtD
Fluocinolone Acetonide—Prednisolone—Prednisone—hematologic cancer	0.00109	0.00639	CrCrCtD
Fluocinolone Acetonide—Methylprednisolone—Prednisolone—hematologic cancer	0.00109	0.00638	CrCrCtD
Fluocinolone Acetonide—PLA2G4A—hematopoietic system—hematologic cancer	0.000577	0.115	CbGeAlD
Fluocinolone Acetonide—SERPINA6—hematopoietic system—hematologic cancer	0.000574	0.114	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—blood—hematologic cancer	0.000382	0.0761	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—Raltitrexed—Methotrexate—hematologic cancer	0.000381	0.604	CbGdCrCtD
Fluocinolone Acetonide—SERPINA6—blood—hematologic cancer	0.00038	0.0758	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—bone marrow—hematologic cancer	0.00037	0.0737	CbGeAlD
Fluocinolone Acetonide—SERPINA6—bone marrow—hematologic cancer	0.000368	0.0734	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—lung—hematologic cancer	0.000335	0.0667	CbGeAlD
Fluocinolone Acetonide—SERPINA6—lung—hematologic cancer	0.000333	0.0665	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—testis—hematologic cancer	0.000316	0.063	CbGeAlD
Fluocinolone Acetonide—NR3C1—hematopoietic system—hematologic cancer	0.000251	0.0501	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—lymph node—hematologic cancer	0.000229	0.0456	CbGeAlD
Fluocinolone Acetonide—NR3C1—gonad—hematologic cancer	0.000191	0.0381	CbGeAlD
Fluocinolone Acetonide—NR3C1—blood—hematologic cancer	0.000167	0.0332	CbGeAlD
Fluocinolone Acetonide—NR3C1—bone marrow—hematologic cancer	0.000161	0.0321	CbGeAlD
Fluocinolone Acetonide—NR3C1—lung—hematologic cancer	0.000146	0.0291	CbGeAlD
Fluocinolone Acetonide—NR3C1—testis—hematologic cancer	0.000138	0.0275	CbGeAlD
Fluocinolone Acetonide—NR3C1—lymph node—hematologic cancer	9.99e-05	0.0199	CbGeAlD
Fluocinolone Acetonide—Difluprednate—NR3C1—hematologic cancer	5.23e-05	0.0504	CrCbGaD
Fluocinolone Acetonide—Clocortolone—NR3C1—hematologic cancer	5.07e-05	0.0488	CrCbGaD
Fluocinolone Acetonide—Desonide—NR3C1—hematologic cancer	4.8e-05	0.0462	CrCbGaD
Fluocinolone Acetonide—Diflorasone—NR3C1—hematologic cancer	4.8e-05	0.0462	CrCbGaD
Fluocinolone Acetonide—Desoximetasone—NR3C1—hematologic cancer	4.68e-05	0.0451	CrCbGaD
Fluocinolone Acetonide—Fludrocortisone—AR—hematologic cancer	4.56e-05	0.0439	CrCbGaD
Fluocinolone Acetonide—Flurandrenolide—NR3C1—hematologic cancer	4.1e-05	0.0395	CrCbGaD
Fluocinolone Acetonide—Flumethasone Pivalate—NR3C1—hematologic cancer	4.03e-05	0.0388	CrCbGaD
Fluocinolone Acetonide—Halobetasol Propionate—NR3C1—hematologic cancer	3.97e-05	0.0382	CrCbGaD
Fluocinolone Acetonide—Amcinonide—NR3C1—hematologic cancer	3.69e-05	0.0355	CrCbGaD
Fluocinolone Acetonide—Budesonide—NR3C1—hematologic cancer	3.69e-05	0.0355	CrCbGaD
Fluocinolone Acetonide—Fluticasone furoate—NR3C1—hematologic cancer	3.62e-05	0.0348	CrCbGaD
Fluocinolone Acetonide—Mometasone—NR3C1—hematologic cancer	3.51e-05	0.0338	CrCbGaD
Fluocinolone Acetonide—Rimexolone—NR3C1—hematologic cancer	3.47e-05	0.0334	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Betamethasone—Dexamethasone—hematologic cancer	3.28e-05	0.052	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—Dexamethasone—Betamethasone—hematologic cancer	3.28e-05	0.052	CbGdCrCtD
Fluocinolone Acetonide—Fluocinonide—NR3C1—hematologic cancer	3.27e-05	0.0315	CrCbGaD
Fluocinolone Acetonide—Beclomethasone—NR3C1—hematologic cancer	3.27e-05	0.0315	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Betamethasone—Triamcinolone—hematologic cancer	3.2e-05	0.0508	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—Dexamethasone—Triamcinolone—hematologic cancer	3.2e-05	0.0508	CbGdCrCtD
Fluocinolone Acetonide—Alclometasone—NR3C1—hematologic cancer	3.18e-05	0.0306	CrCbGaD
Fluocinolone Acetonide—Flunisolide—NR3C1—hematologic cancer	3.09e-05	0.0298	CrCbGaD
Fluocinolone Acetonide—Fludrocortisone—NR3C1—hematologic cancer	3.09e-05	0.0298	CrCbGaD
Fluocinolone Acetonide—Clobetasol propionate—NR3C1—hematologic cancer	3.09e-05	0.0298	CrCbGaD
Fluocinolone Acetonide—Paramethasone—NR3C1—hematologic cancer	3.06e-05	0.0294	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Dexamethasone—Prednisone—hematologic cancer	3.04e-05	0.0482	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—Betamethasone—Prednisone—hematologic cancer	3.04e-05	0.0482	CbGdCrCtD
Fluocinolone Acetonide—Fluorometholone—NR3C1—hematologic cancer	2.98e-05	0.0287	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Dexamethasone—Prednisolone—hematologic cancer	2.97e-05	0.047	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—Betamethasone—Prednisolone—hematologic cancer	2.97e-05	0.047	CbGdCrCtD
Fluocinolone Acetonide—Methylprednisolone—NR3C1—hematologic cancer	2.88e-05	0.0277	CrCbGaD
Fluocinolone Acetonide—Triamcinolone—NR3C1—hematologic cancer	2.43e-05	0.0234	CrCbGaD
Fluocinolone Acetonide—Fluticasone Propionate—NR3C1—hematologic cancer	2.17e-05	0.0209	CrCbGaD
Fluocinolone Acetonide—Prednisolone—NR3C1—hematologic cancer	2.03e-05	0.0196	CrCbGaD
Fluocinolone Acetonide—Betamethasone—NR3C1—hematologic cancer	1.99e-05	0.0192	CrCbGaD
Fluocinolone Acetonide—Fluticasone furoate—ABCB1—hematologic cancer	1.75e-05	0.0168	CrCbGaD
Fluocinolone Acetonide—Methylprednisolone—ABCB1—hematologic cancer	1.39e-05	0.0134	CrCbGaD
Fluocinolone Acetonide—Dexamethasone—ABCG2—hematologic cancer	1.34e-05	0.0129	CrCbGaD
Fluocinolone Acetonide—Dexamethasone—NR3C1—hematologic cancer	1.16e-05	0.0111	CrCbGaD
Fluocinolone Acetonide—Prednisolone—ABCB1—hematologic cancer	9.81e-06	0.00944	CrCbGaD
Fluocinolone Acetonide—Betamethasone—ABCB1—hematologic cancer	9.61e-06	0.00925	CrCbGaD
Fluocinolone Acetonide—Infection—Triamcinolone—hematologic cancer	9.13e-06	0.000168	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Ifosfamide—hematologic cancer	9.08e-06	0.000167	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Prednisone—hematologic cancer	9.03e-06	0.000167	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Thalidomide—hematologic cancer	9.02e-06	0.000166	CcSEcCtD
Fluocinolone Acetonide—Nausea—Bortezomib—hematologic cancer	8.98e-06	0.000166	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Mitoxantrone—hematologic cancer	8.97e-06	0.000166	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Irinotecan—hematologic cancer	8.97e-06	0.000166	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Thiotepa—hematologic cancer	8.97e-06	0.000165	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Carmustine—hematologic cancer	8.96e-06	0.000165	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Prednisone—hematologic cancer	8.95e-06	0.000165	CcSEcCtD
Fluocinolone Acetonide—Nausea—Bleomycin—hematologic cancer	8.92e-06	0.000164	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Epirubicin—hematologic cancer	8.9e-06	0.000164	CcSEcCtD
Fluocinolone Acetonide—Infestation—Epirubicin—hematologic cancer	8.9e-06	0.000164	CcSEcCtD
Fluocinolone Acetonide—Erythema—Prednisone—hematologic cancer	8.9e-06	0.000164	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Prednisone—hematologic cancer	8.9e-06	0.000164	CcSEcCtD
Fluocinolone Acetonide—Rash—Thiotepa—hematologic cancer	8.89e-06	0.000164	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Thiotepa—hematologic cancer	8.88e-06	0.000164	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Alitretinoin—hematologic cancer	8.88e-06	0.000164	CcSEcCtD
Fluocinolone Acetonide—Headache—Thiotepa—hematologic cancer	8.84e-06	0.000163	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Ifosfamide—hematologic cancer	8.78e-06	0.000162	CcSEcCtD
Fluocinolone Acetonide—Nausea—Vinorelbine—hematologic cancer	8.77e-06	0.000162	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Etoposide—hematologic cancer	8.75e-06	0.000161	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Cisplatin—hematologic cancer	8.74e-06	0.000161	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Thalidomide—hematologic cancer	8.67e-06	0.00016	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Carmustine—hematologic cancer	8.66e-06	0.00016	CcSEcCtD
Fluocinolone Acetonide—Pain—Etoposide—hematologic cancer	8.66e-06	0.00016	CcSEcCtD
Fluocinolone Acetonide—Rash—Thalidomide—hematologic cancer	8.6e-06	0.000159	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Thalidomide—hematologic cancer	8.59e-06	0.000159	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Doxorubicin—hematologic cancer	8.59e-06	0.000158	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Alitretinoin—hematologic cancer	8.58e-06	0.000158	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Vincristine—hematologic cancer	8.56e-06	0.000158	CcSEcCtD
Fluocinolone Acetonide—Headache—Thalidomide—hematologic cancer	8.55e-06	0.000158	CcSEcCtD
Fluocinolone Acetonide—Pain—Prednisolone—hematologic cancer	8.55e-06	0.000158	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Ifosfamide—hematologic cancer	8.48e-06	0.000156	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Gemcitabine—hematologic cancer	8.39e-06	0.000155	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Prednisone—hematologic cancer	8.39e-06	0.000155	CcSEcCtD
Fluocinolone Acetonide—Nausea—Thiotepa—hematologic cancer	8.38e-06	0.000155	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	8.37e-06	0.000154	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Epirubicin—hematologic cancer	8.35e-06	0.000154	CcSEcCtD
Fluocinolone Acetonide—Oedema—Dexamethasone—hematologic cancer	8.34e-06	0.000154	CcSEcCtD
Fluocinolone Acetonide—Oedema—Betamethasone—hematologic cancer	8.34e-06	0.000154	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Irinotecan—hematologic cancer	8.33e-06	0.000154	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Mitoxantrone—hematologic cancer	8.33e-06	0.000154	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Carmustine—hematologic cancer	8.33e-06	0.000154	CcSEcCtD
Fluocinolone Acetonide—Infection—Dexamethasone—hematologic cancer	8.28e-06	0.000153	CcSEcCtD
Fluocinolone Acetonide—Infection—Betamethasone—hematologic cancer	8.28e-06	0.000153	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Vincristine—hematologic cancer	8.27e-06	0.000153	CcSEcCtD
Fluocinolone Acetonide—Rash—Carmustine—hematologic cancer	8.26e-06	0.000152	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Carmustine—hematologic cancer	8.25e-06	0.000152	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Alitretinoin—hematologic cancer	8.25e-06	0.000152	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Doxorubicin—hematologic cancer	8.24e-06	0.000152	CcSEcCtD
Fluocinolone Acetonide—Infestation—Doxorubicin—hematologic cancer	8.24e-06	0.000152	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Methotrexate—hematologic cancer	8.23e-06	0.000152	CcSEcCtD
Fluocinolone Acetonide—Headache—Carmustine—hematologic cancer	8.21e-06	0.000151	CcSEcCtD
Fluocinolone Acetonide—Rash—Alitretinoin—hematologic cancer	8.18e-06	0.000151	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Betamethasone—hematologic cancer	8.18e-06	0.000151	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Dexamethasone—hematologic cancer	8.18e-06	0.000151	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Alitretinoin—hematologic cancer	8.18e-06	0.000151	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Ifosfamide—hematologic cancer	8.16e-06	0.00015	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Cisplatin—hematologic cancer	8.15e-06	0.00015	CcSEcCtD
Fluocinolone Acetonide—Headache—Alitretinoin—hematologic cancer	8.13e-06	0.00015	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Gemcitabine—hematologic cancer	8.12e-06	0.00015	CcSEcCtD
Fluocinolone Acetonide—Nausea—Thalidomide—hematologic cancer	8.1e-06	0.000149	CcSEcCtD
Fluocinolone Acetonide—Rash—Ifosfamide—hematologic cancer	8.09e-06	0.000149	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Ifosfamide—hematologic cancer	8.08e-06	0.000149	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Irinotecan—hematologic cancer	8.05e-06	0.000149	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Epirubicin—hematologic cancer	8.01e-06	0.000148	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Etoposide—hematologic cancer	8.01e-06	0.000148	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Prednisone—hematologic cancer	7.99e-06	0.000147	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Methotrexate—hematologic cancer	7.98e-06	0.000147	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Vincristine—hematologic cancer	7.95e-06	0.000147	CcSEcCtD
Fluocinolone Acetonide—Rash—Vincristine—hematologic cancer	7.89e-06	0.000145	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Vincristine—hematologic cancer	7.88e-06	0.000145	CcSEcCtD
Fluocinolone Acetonide—Pain—Triamcinolone—hematologic cancer	7.86e-06	0.000145	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Epirubicin—hematologic cancer	7.86e-06	0.000145	CcSEcCtD
Fluocinolone Acetonide—Headache—Vincristine—hematologic cancer	7.84e-06	0.000145	CcSEcCtD
Fluocinolone Acetonide—Nausea—Carmustine—hematologic cancer	7.78e-06	0.000144	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Mitoxantrone—hematologic cancer	7.74e-06	0.000143	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Irinotecan—hematologic cancer	7.74e-06	0.000143	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Doxorubicin—hematologic cancer	7.73e-06	0.000143	CcSEcCtD
Fluocinolone Acetonide—Nausea—Alitretinoin—hematologic cancer	7.71e-06	0.000142	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Epirubicin—hematologic cancer	7.7e-06	0.000142	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Methotrexate—hematologic cancer	7.7e-06	0.000142	CcSEcCtD
Fluocinolone Acetonide—Rash—Mitoxantrone—hematologic cancer	7.68e-06	0.000142	CcSEcCtD
Fluocinolone Acetonide—Rash—Irinotecan—hematologic cancer	7.68e-06	0.000142	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Mitoxantrone—hematologic cancer	7.67e-06	0.000142	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Irinotecan—hematologic cancer	7.67e-06	0.000142	CcSEcCtD
Fluocinolone Acetonide—Headache—Mitoxantrone—hematologic cancer	7.63e-06	0.000141	CcSEcCtD
Fluocinolone Acetonide—Headache—Irinotecan—hematologic cancer	7.63e-06	0.000141	CcSEcCtD
Fluocinolone Acetonide—Nausea—Ifosfamide—hematologic cancer	7.62e-06	0.000141	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	7.6e-06	0.00014	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Betamethasone—hematologic cancer	7.6e-06	0.00014	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Prednisone—hematologic cancer	7.57e-06	0.00014	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Cisplatin—hematologic cancer	7.57e-06	0.00014	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Methotrexate—hematologic cancer	7.55e-06	0.000139	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Gemcitabine—hematologic cancer	7.54e-06	0.000139	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Methotrexate—hematologic cancer	7.48e-06	0.000138	CcSEcCtD
Fluocinolone Acetonide—Rash—Gemcitabine—hematologic cancer	7.48e-06	0.000138	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Gemcitabine—hematologic cancer	7.47e-06	0.000138	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Epirubicin—hematologic cancer	7.47e-06	0.000138	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Etoposide—hematologic cancer	7.46e-06	0.000138	CcSEcCtD
Fluocinolone Acetonide—Erythema—Methotrexate—hematologic cancer	7.44e-06	0.000137	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Methotrexate—hematologic cancer	7.44e-06	0.000137	CcSEcCtD
Fluocinolone Acetonide—Headache—Gemcitabine—hematologic cancer	7.43e-06	0.000137	CcSEcCtD
Fluocinolone Acetonide—Nausea—Vincristine—hematologic cancer	7.43e-06	0.000137	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Doxorubicin—hematologic cancer	7.42e-06	0.000137	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Prednisolone—hematologic cancer	7.36e-06	0.000136	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Methotrexate—hematologic cancer	7.28e-06	0.000134	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Doxorubicin—hematologic cancer	7.27e-06	0.000134	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Triamcinolone—hematologic cancer	7.26e-06	0.000134	CcSEcCtD
Fluocinolone Acetonide—Oedema—Prednisone—hematologic cancer	7.26e-06	0.000134	CcSEcCtD
Fluocinolone Acetonide—Nausea—Mitoxantrone—hematologic cancer	7.24e-06	0.000133	CcSEcCtD
Fluocinolone Acetonide—Nausea—Irinotecan—hematologic cancer	7.24e-06	0.000133	CcSEcCtD
Fluocinolone Acetonide—Infection—Prednisone—hematologic cancer	7.21e-06	0.000133	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Epirubicin—hematologic cancer	7.2e-06	0.000133	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Betamethasone—hematologic cancer	7.2e-06	0.000133	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Dexamethasone—hematologic cancer	7.2e-06	0.000133	CcSEcCtD
Fluocinolone Acetonide—Back pain—Methotrexate—hematologic cancer	7.19e-06	0.000133	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Etoposide—hematologic cancer	7.17e-06	0.000132	CcSEcCtD
Fluocinolone Acetonide—Pain—Dexamethasone—hematologic cancer	7.13e-06	0.000132	CcSEcCtD
Fluocinolone Acetonide—Pain—Betamethasone—hematologic cancer	7.13e-06	0.000132	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Doxorubicin—hematologic cancer	7.13e-06	0.000131	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Prednisone—hematologic cancer	7.12e-06	0.000131	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Epirubicin—hematologic cancer	7.06e-06	0.00013	CcSEcCtD
Fluocinolone Acetonide—Nausea—Gemcitabine—hematologic cancer	7.05e-06	0.00013	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Cisplatin—hematologic cancer	7.03e-06	0.00013	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Methotrexate—hematologic cancer	7.01e-06	0.000129	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Epirubicin—hematologic cancer	7e-06	0.000129	CcSEcCtD
Fluocinolone Acetonide—Rash—Cisplatin—hematologic cancer	6.97e-06	0.000129	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Cisplatin—hematologic cancer	6.97e-06	0.000129	CcSEcCtD
Fluocinolone Acetonide—Erythema—Epirubicin—hematologic cancer	6.96e-06	0.000128	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Epirubicin—hematologic cancer	6.96e-06	0.000128	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Etoposide—hematologic cancer	6.93e-06	0.000128	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Doxorubicin—hematologic cancer	6.91e-06	0.000128	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LEF1—hematologic cancer	6.87e-06	0.000309	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—TXN—hematologic cancer	6.87e-06	0.000309	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCC3—hematologic cancer	6.87e-06	0.000309	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTO1—hematologic cancer	6.87e-06	0.000309	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	6.82e-06	0.000307	CbGpPWpGaD
Fluocinolone Acetonide—Dysgeusia—Epirubicin—hematologic cancer	6.81e-06	0.000126	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Triamcinolone—hematologic cancer	6.77e-06	0.000125	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—CDKN2B—hematologic cancer	6.76e-06	0.000304	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GNA13—hematologic cancer	6.75e-06	0.000304	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	6.74e-06	0.000304	CbGpPWpGaD
Fluocinolone Acetonide—Back pain—Epirubicin—hematologic cancer	6.73e-06	0.000124	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SPHK1—hematologic cancer	6.72e-06	0.000303	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Etoposide—hematologic cancer	6.7e-06	0.000124	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MAPK14—hematologic cancer	6.7e-06	0.000302	CbGpPWpGaD
Fluocinolone Acetonide—Vertigo—Methotrexate—hematologic cancer	6.68e-06	0.000123	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TNF—hematologic cancer	6.68e-06	0.000301	CbGpPWpGaD
Fluocinolone Acetonide—Mediastinal disorder—Doxorubicin—hematologic cancer	6.67e-06	0.000123	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TIAM1—hematologic cancer	6.64e-06	0.000299	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NCOR2—hematologic cancer	6.63e-06	0.000299	CbGpPWpGaD
Fluocinolone Acetonide—Musculoskeletal discomfort—Prednisone—hematologic cancer	6.62e-06	0.000122	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	6.61e-06	0.000298	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Prednisolone—hematologic cancer	6.61e-06	0.000122	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Betamethasone—hematologic cancer	6.59e-06	0.000122	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Dexamethasone—hematologic cancer	6.59e-06	0.000122	CcSEcCtD
Fluocinolone Acetonide—Nausea—Cisplatin—hematologic cancer	6.57e-06	0.000121	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Epirubicin—hematologic cancer	6.56e-06	0.000121	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Doxorubicin—hematologic cancer	6.54e-06	0.000121	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Triamcinolone—hematologic cancer	6.5e-06	0.00012	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—FN1—hematologic cancer	6.49e-06	0.000292	CbGpPWpGaD
Fluocinolone Acetonide—Cough—Methotrexate—hematologic cancer	6.49e-06	0.00012	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Doxorubicin—hematologic cancer	6.48e-06	0.00012	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—UGT1A1—hematologic cancer	6.46e-06	0.000291	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Etoposide—hematologic cancer	6.44e-06	0.000119	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—JAK3—hematologic cancer	6.44e-06	0.00029	CbGpPWpGaD
Fluocinolone Acetonide—Erythema—Doxorubicin—hematologic cancer	6.44e-06	0.000119	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Doxorubicin—hematologic cancer	6.44e-06	0.000119	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—NCOR1—hematologic cancer	6.41e-06	0.000289	CbGpPWpGaD
Fluocinolone Acetonide—Rash—Etoposide—hematologic cancer	6.39e-06	0.000118	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Etoposide—hematologic cancer	6.38e-06	0.000118	CcSEcCtD
Fluocinolone Acetonide—Headache—Etoposide—hematologic cancer	6.35e-06	0.000117	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCR4—hematologic cancer	6.33e-06	0.000285	CbGpPWpGaD
Fluocinolone Acetonide—Arthralgia—Methotrexate—hematologic cancer	6.33e-06	0.000117	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	6.32e-06	0.000285	CbGpPWpGaD
Fluocinolone Acetonide—Dysgeusia—Doxorubicin—hematologic cancer	6.31e-06	0.000116	CcSEcCtD
Fluocinolone Acetonide—Rash—Prednisolone—hematologic cancer	6.3e-06	0.000116	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Prednisolone—hematologic cancer	6.29e-06	0.000116	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC22A1—hematologic cancer	6.28e-06	0.000283	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CRABP1—hematologic cancer	6.28e-06	0.000283	CbGpPWpGaD
Fluocinolone Acetonide—Headache—Prednisolone—hematologic cancer	6.26e-06	0.000115	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Epirubicin—hematologic cancer	6.25e-06	0.000115	CcSEcCtD
Fluocinolone Acetonide—Back pain—Doxorubicin—hematologic cancer	6.23e-06	0.000115	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CG—hematologic cancer	6.21e-06	0.00028	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCR7—hematologic cancer	6.18e-06	0.000278	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL13—hematologic cancer	6.18e-06	0.000278	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALOX5—hematologic cancer	6.12e-06	0.000276	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	6.12e-06	0.000276	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AGO2—hematologic cancer	6.11e-06	0.000275	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL3—hematologic cancer	6.11e-06	0.000275	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PTPN11—hematologic cancer	6.1e-06	0.000275	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NCOR2—hematologic cancer	6.09e-06	0.000275	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Triamcinolone—hematologic cancer	6.08e-06	0.000112	CcSEcCtD
Fluocinolone Acetonide—Cough—Epirubicin—hematologic cancer	6.07e-06	0.000112	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Doxorubicin—hematologic cancer	6.07e-06	0.000112	CcSEcCtD
Fluocinolone Acetonide—Infection—Methotrexate—hematologic cancer	6.03e-06	0.000111	CcSEcCtD
Fluocinolone Acetonide—Nausea—Etoposide—hematologic cancer	6.02e-06	0.000111	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL3RA—hematologic cancer	6.02e-06	0.000271	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CRKL—hematologic cancer	6.02e-06	0.000271	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—DNMT3B—hematologic cancer	5.99e-06	0.00027	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—H3F3B—hematologic cancer	5.99e-06	0.00027	CbGpPWpGaD
Fluocinolone Acetonide—Nervous system disorder—Methotrexate—hematologic cancer	5.95e-06	0.00011	CcSEcCtD
Fluocinolone Acetonide—Nausea—Prednisolone—hematologic cancer	5.94e-06	0.000109	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NUP98—hematologic cancer	5.93e-06	0.000267	CbGpPWpGaD
Fluocinolone Acetonide—Arthralgia—Epirubicin—hematologic cancer	5.92e-06	0.000109	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—RASGRP1—hematologic cancer	5.91e-06	0.000266	CbGpPWpGaD
Fluocinolone Acetonide—Pruritus—Betamethasone—hematologic cancer	5.9e-06	0.000109	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Dexamethasone—hematologic cancer	5.9e-06	0.000109	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Triamcinolone—hematologic cancer	5.84e-06	0.000108	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RGS2—hematologic cancer	5.81e-06	0.000262	CbGpPWpGaD
Fluocinolone Acetonide—Rash—Triamcinolone—hematologic cancer	5.79e-06	0.000107	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Triamcinolone—hematologic cancer	5.79e-06	0.000107	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Doxorubicin—hematologic cancer	5.78e-06	0.000107	CcSEcCtD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—TNF—hematologic cancer	5.77e-06	0.00026	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CREBBP—hematologic cancer	5.76e-06	0.000259	CbGpPWpGaD
Fluocinolone Acetonide—Headache—Triamcinolone—hematologic cancer	5.76e-06	0.000106	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ADCY7—hematologic cancer	5.75e-06	0.000259	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NCOA3—hematologic cancer	5.75e-06	0.000259	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CMA1—hematologic cancer	5.74e-06	0.000259	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TRIO—hematologic cancer	5.74e-06	0.000259	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TRH—hematologic cancer	5.74e-06	0.000259	CbGpPWpGaD
Fluocinolone Acetonide—Body temperature increased—Prednisone—hematologic cancer	5.74e-06	0.000106	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NUP214—hematologic cancer	5.71e-06	0.000257	CbGpPWpGaD
Fluocinolone Acetonide—Diarrhoea—Betamethasone—hematologic cancer	5.71e-06	0.000105	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Dexamethasone—hematologic cancer	5.71e-06	0.000105	CcSEcCtD
Fluocinolone Acetonide—Oedema—Epirubicin—hematologic cancer	5.68e-06	0.000105	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.65e-06	0.000255	CbGpPWpGaD
Fluocinolone Acetonide—Infection—Epirubicin—hematologic cancer	5.64e-06	0.000104	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	5.63e-06	0.000254	CbGpPWpGaD
Fluocinolone Acetonide—Cough—Doxorubicin—hematologic cancer	5.62e-06	0.000104	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AGO2—hematologic cancer	5.62e-06	0.000253	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SPHK1—hematologic cancer	5.62e-06	0.000253	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCG2—hematologic cancer	5.6e-06	0.000252	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MTR—hematologic cancer	5.6e-06	0.000252	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—ABCB1—hematologic cancer	5.59e-06	0.00538	CrCbGaD
Fluocinolone Acetonide—Nervous system disorder—Epirubicin—hematologic cancer	5.57e-06	0.000103	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HDAC9—hematologic cancer	5.56e-06	0.000251	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LPAR1—hematologic cancer	5.56e-06	0.000251	CbGpPWpGaD
Fluocinolone Acetonide—Musculoskeletal discomfort—Methotrexate—hematologic cancer	5.53e-06	0.000102	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Dexamethasone—hematologic cancer	5.51e-06	0.000102	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Betamethasone—hematologic cancer	5.51e-06	0.000102	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—H3F3B—hematologic cancer	5.5e-06	0.000248	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ENO2—hematologic cancer	5.49e-06	0.000247	CbGpPWpGaD
Fluocinolone Acetonide—Arthralgia—Doxorubicin—hematologic cancer	5.48e-06	0.000101	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Gene Expression—RPS14—hematologic cancer	5.48e-06	0.000247	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CD—hematologic cancer	5.46e-06	0.000246	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Triamcinolone—hematologic cancer	5.46e-06	0.000101	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Gene Expression—NUP98—hematologic cancer	5.39e-06	0.000243	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—IL6—hematologic cancer	5.39e-06	0.000243	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—ALB—hematologic cancer	5.39e-06	0.000243	CbGpPWpGaD
Fluocinolone Acetonide—Hypersensitivity—Prednisone—hematologic cancer	5.35e-06	9.87e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTT1—hematologic cancer	5.32e-06	0.00024	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GRB2—hematologic cancer	5.31e-06	0.000239	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Dexamethasone—hematologic cancer	5.3e-06	9.78e-05	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Betamethasone—hematologic cancer	5.3e-06	9.78e-05	CcSEcCtD
Fluocinolone Acetonide—Rash—Dexamethasone—hematologic cancer	5.26e-06	9.7e-05	CcSEcCtD
Fluocinolone Acetonide—Rash—Betamethasone—hematologic cancer	5.26e-06	9.7e-05	CcSEcCtD
Fluocinolone Acetonide—Oedema—Doxorubicin—hematologic cancer	5.25e-06	9.69e-05	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Betamethasone—hematologic cancer	5.25e-06	9.69e-05	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Dexamethasone—hematologic cancer	5.25e-06	9.69e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.24e-06	0.000236	CbGpPWpGaD
Fluocinolone Acetonide—Gastrointestinal disorder—Methotrexate—hematologic cancer	5.24e-06	9.66e-05	CcSEcCtD
Fluocinolone Acetonide—Headache—Betamethasone—hematologic cancer	5.22e-06	9.64e-05	CcSEcCtD
Fluocinolone Acetonide—Headache—Dexamethasone—hematologic cancer	5.22e-06	9.64e-05	CcSEcCtD
Fluocinolone Acetonide—Infection—Doxorubicin—hematologic cancer	5.22e-06	9.63e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SDC1—hematologic cancer	5.2e-06	0.000234	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NUP214—hematologic cancer	5.2e-06	0.000234	CbGpPWpGaD
Fluocinolone Acetonide—Pain—Methotrexate—hematologic cancer	5.19e-06	9.57e-05	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Epirubicin—hematologic cancer	5.17e-06	9.54e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	5.17e-06	0.000233	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3R1—hematologic cancer	5.16e-06	0.000232	CbGpPWpGaD
Fluocinolone Acetonide—Nervous system disorder—Doxorubicin—hematologic cancer	5.15e-06	9.51e-05	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Prednisone—hematologic cancer	5.14e-06	9.48e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PDE4B—hematologic cancer	5.12e-06	0.000231	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CNR2—hematologic cancer	5.12e-06	0.000231	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGF19—hematologic cancer	5.07e-06	0.000229	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—ESR1—hematologic cancer	5.03e-06	0.000227	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RAC2—hematologic cancer	5.03e-06	0.000227	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—JAK2—hematologic cancer	5.01e-06	0.000226	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—DKK1—hematologic cancer	4.99e-06	0.000225	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.97e-06	0.000224	CbGpPWpGaD
Fluocinolone Acetonide—Diarrhoea—Prednisone—hematologic cancer	4.97e-06	9.16e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—STAT5B—hematologic cancer	4.96e-06	0.000223	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Betamethasone—hematologic cancer	4.95e-06	9.14e-05	CcSEcCtD
Fluocinolone Acetonide—Nausea—Dexamethasone—hematologic cancer	4.95e-06	9.14e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.91e-06	0.000221	CbGpPWpGaD
Fluocinolone Acetonide—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.9e-06	9.04e-05	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—NOTCH1—hematologic cancer	4.87e-06	0.000219	CbGpPWpGaD
Fluocinolone Acetonide—Pain—Epirubicin—hematologic cancer	4.86e-06	8.96e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADCY7—hematologic cancer	4.81e-06	0.000217	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Prednisone—hematologic cancer	4.8e-06	8.86e-05	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Methotrexate—hematologic cancer	4.8e-06	8.85e-05	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Gene Expression—HSPB1—hematologic cancer	4.79e-06	0.000216	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—EIF4EBP1—hematologic cancer	4.79e-06	0.000216	CbGpPWpGaD
Fluocinolone Acetonide—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	4.79e-06	8.83e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CB—hematologic cancer	4.76e-06	0.000214	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CSF2—hematologic cancer	4.75e-06	0.000214	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.69e-06	0.000211	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—XIAP—hematologic cancer	4.68e-06	0.000211	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL6—hematologic cancer	4.66e-06	0.00021	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Prednisone—hematologic cancer	4.62e-06	8.52e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	4.6e-06	0.000207	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SMC1A—hematologic cancer	4.59e-06	0.000207	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—JAK1—hematologic cancer	4.58e-06	0.000206	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PRKCG—hematologic cancer	4.58e-06	0.000206	CbGpPWpGaD
Fluocinolone Acetonide—Rash—Prednisone—hematologic cancer	4.58e-06	8.45e-05	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Prednisone—hematologic cancer	4.57e-06	8.44e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SH2B3—hematologic cancer	4.56e-06	0.000205	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SMARCA4—hematologic cancer	4.56e-06	0.000205	CbGpPWpGaD
Fluocinolone Acetonide—Headache—Prednisone—hematologic cancer	4.55e-06	8.39e-05	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4.54e-06	8.37e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GZMB—hematologic cancer	4.53e-06	0.000204	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—H3F3A—hematologic cancer	4.49e-06	0.000203	CbGpPWpGaD
Fluocinolone Acetonide—Pain—Doxorubicin—hematologic cancer	4.49e-06	8.29e-05	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Epirubicin—hematologic cancer	4.49e-06	8.28e-05	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Methotrexate—hematologic cancer	4.47e-06	8.25e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CTNNA1—hematologic cancer	4.43e-06	0.000199	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NQO1—hematologic cancer	4.42e-06	0.000199	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CD44—hematologic cancer	4.42e-06	0.000199	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—CREBBP—hematologic cancer	4.41e-06	0.000199	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EIF4EBP1—hematologic cancer	4.4e-06	0.000198	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HSPB1—hematologic cancer	4.4e-06	0.000198	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCL3—hematologic cancer	4.4e-06	0.000198	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IL2—hematologic cancer	4.37e-06	0.000197	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTHLH—hematologic cancer	4.35e-06	0.000196	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SDC1—hematologic cancer	4.35e-06	0.000196	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.33e-06	0.000195	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Prednisone—hematologic cancer	4.31e-06	7.96e-05	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Gene Expression—EZH2—hematologic cancer	4.31e-06	0.000194	CbGpPWpGaD
Fluocinolone Acetonide—Pruritus—Methotrexate—hematologic cancer	4.29e-06	7.92e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL2RA—hematologic cancer	4.28e-06	0.000193	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTGER4—hematologic cancer	4.24e-06	0.000191	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PARP1—hematologic cancer	4.22e-06	0.00019	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LCK—hematologic cancer	4.21e-06	0.00019	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYCS—hematologic cancer	4.19e-06	0.000189	CbGpPWpGaD
Fluocinolone Acetonide—Hypersensitivity—Epirubicin—hematologic cancer	4.18e-06	7.72e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HSP90AA1—hematologic cancer	4.16e-06	0.000187	CbGpPWpGaD
Fluocinolone Acetonide—Body temperature increased—Doxorubicin—hematologic cancer	4.15e-06	7.66e-05	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Methotrexate—hematologic cancer	4.15e-06	7.66e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—H3F3A—hematologic cancer	4.13e-06	0.000186	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HDAC2—hematologic cancer	4.07e-06	0.000183	CbGpPWpGaD
Fluocinolone Acetonide—Pruritus—Epirubicin—hematologic cancer	4.02e-06	7.41e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKCZ—hematologic cancer	4.02e-06	0.000181	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Methotrexate—hematologic cancer	4.01e-06	7.4e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—EP300—hematologic cancer	3.92e-06	0.000177	CbGpPWpGaD
Fluocinolone Acetonide—Diarrhoea—Epirubicin—hematologic cancer	3.89e-06	7.17e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PARP1—hematologic cancer	3.88e-06	0.000175	CbGpPWpGaD
Fluocinolone Acetonide—Hypersensitivity—Doxorubicin—hematologic cancer	3.87e-06	7.14e-05	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Methotrexate—hematologic cancer	3.86e-06	7.12e-05	CcSEcCtD
Fluocinolone Acetonide—Rash—Methotrexate—hematologic cancer	3.83e-06	7.06e-05	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Methotrexate—hematologic cancer	3.82e-06	7.05e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FBXW7—hematologic cancer	3.82e-06	0.000172	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SRC—hematologic cancer	3.81e-06	0.000172	CbGpPWpGaD
Fluocinolone Acetonide—Headache—Methotrexate—hematologic cancer	3.8e-06	7.01e-05	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Epirubicin—hematologic cancer	3.76e-06	6.93e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.74e-06	0.000169	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HDAC2—hematologic cancer	3.74e-06	0.000169	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCR4—hematologic cancer	3.74e-06	0.000169	CbGpPWpGaD
Fluocinolone Acetonide—Pruritus—Doxorubicin—hematologic cancer	3.72e-06	6.86e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—VEGFA—hematologic cancer	3.71e-06	0.000167	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTP1—hematologic cancer	3.69e-06	0.000166	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NRAS—hematologic cancer	3.67e-06	0.000165	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CBL—hematologic cancer	3.65e-06	0.000164	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Epirubicin—hematologic cancer	3.61e-06	6.66e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL3—hematologic cancer	3.61e-06	0.000163	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Methotrexate—hematologic cancer	3.6e-06	6.65e-05	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Doxorubicin—hematologic cancer	3.6e-06	6.63e-05	CcSEcCtD
Fluocinolone Acetonide—Rash—Epirubicin—hematologic cancer	3.58e-06	6.61e-05	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Epirubicin—hematologic cancer	3.58e-06	6.6e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.57e-06	0.000161	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CG—hematologic cancer	3.56e-06	0.000161	CbGpPWpGaD
Fluocinolone Acetonide—Headache—Epirubicin—hematologic cancer	3.56e-06	6.56e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTPN1—hematologic cancer	3.55e-06	0.00016	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AR—hematologic cancer	3.53e-06	0.000159	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MAPK3—hematologic cancer	3.51e-06	0.000158	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PTPN11—hematologic cancer	3.5e-06	0.000158	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCB1—hematologic cancer	3.49e-06	0.000157	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RASGRP1—hematologic cancer	3.49e-06	0.000157	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SYK—hematologic cancer	3.48e-06	0.000157	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HSP90AA1—hematologic cancer	3.48e-06	0.000157	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Doxorubicin—hematologic cancer	3.47e-06	6.41e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TGFB1—hematologic cancer	3.41e-06	0.000154	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CREB1—hematologic cancer	3.39e-06	0.000153	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NCOR1—hematologic cancer	3.39e-06	0.000153	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTM1—hematologic cancer	3.39e-06	0.000153	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Epirubicin—hematologic cancer	3.37e-06	6.22e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—STAT1—hematologic cancer	3.35e-06	0.000151	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Doxorubicin—hematologic cancer	3.34e-06	6.16e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCL2—hematologic cancer	3.32e-06	0.00015	CbGpPWpGaD
Fluocinolone Acetonide—Rash—Doxorubicin—hematologic cancer	3.31e-06	6.11e-05	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Doxorubicin—hematologic cancer	3.31e-06	6.11e-05	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL6R—hematologic cancer	3.31e-06	0.000149	CbGpPWpGaD
Fluocinolone Acetonide—Headache—Doxorubicin—hematologic cancer	3.29e-06	6.07e-05	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Gene Expression—CDKN2B—hematologic cancer	3.25e-06	0.000147	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—KRAS—hematologic cancer	3.16e-06	0.000142	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MAP2K1—hematologic cancer	3.15e-06	0.000142	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GRB2—hematologic cancer	3.14e-06	0.000141	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CD—hematologic cancer	3.13e-06	0.000141	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PDGFA—hematologic cancer	3.13e-06	0.000141	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Doxorubicin—hematologic cancer	3.12e-06	5.76e-05	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Gene Expression—NCOR1—hematologic cancer	3.09e-06	0.000139	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KITLG—hematologic cancer	3.09e-06	0.000139	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—STAT5A—hematologic cancer	3.02e-06	0.000136	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MTHFR—hematologic cancer	3e-06	0.000135	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN2B—hematologic cancer	2.99e-06	0.000135	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3R1—hematologic cancer	2.96e-06	0.000133	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CA—hematologic cancer	2.9e-06	0.000131	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CD86—hematologic cancer	2.89e-06	0.00013	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—JAK2—hematologic cancer	2.88e-06	0.00013	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HES1—hematologic cancer	2.85e-06	0.000128	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NCOR1—hematologic cancer	2.84e-06	0.000128	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TP53—hematologic cancer	2.81e-06	0.000126	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGF1—hematologic cancer	2.8e-06	0.000126	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CSF2—hematologic cancer	2.8e-06	0.000126	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FOXO1—hematologic cancer	2.76e-06	0.000124	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PDGFRB—hematologic cancer	2.76e-06	0.000124	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CB—hematologic cancer	2.73e-06	0.000123	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PDGFRA—hematologic cancer	2.72e-06	0.000122	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKCG—hematologic cancer	2.71e-06	0.000122	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—JAK1—hematologic cancer	2.71e-06	0.000122	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—HRAS—hematologic cancer	2.68e-06	0.000121	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.64e-06	0.000119	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	2.62e-06	0.000118	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL2RA—hematologic cancer	2.53e-06	0.000114	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CG—hematologic cancer	2.52e-06	0.000113	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL2—hematologic cancer	2.51e-06	0.000113	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TERT—hematologic cancer	2.5e-06	0.000113	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MAPK14—hematologic cancer	2.47e-06	0.000111	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PDGFB—hematologic cancer	2.44e-06	0.00011	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—ESR1—hematologic cancer	2.42e-06	0.000109	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TSC2—hematologic cancer	2.38e-06	0.000107	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT1—hematologic cancer	2.37e-06	0.000107	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NOTCH1—hematologic cancer	2.34e-06	0.000106	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CREBBP—hematologic cancer	2.33e-06	0.000105	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGFR3—hematologic cancer	2.29e-06	0.000103	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK14—hematologic cancer	2.27e-06	0.000102	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ESR1—hematologic cancer	2.23e-06	0.0001	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CD—hematologic cancer	2.21e-06	9.97e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FN1—hematologic cancer	2.2e-06	9.91e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALB—hematologic cancer	2.19e-06	9.85e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NFKBIA—hematologic cancer	2.17e-06	9.79e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BAD—hematologic cancer	2.17e-06	9.79e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOTCH1—hematologic cancer	2.15e-06	9.7e-05	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—CREBBP—hematologic cancer	2.12e-06	9.57e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CD80—hematologic cancer	2.11e-06	9.5e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KIT—hematologic cancer	2.11e-06	9.49e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CG—hematologic cancer	2.11e-06	9.49e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—NRAS—hematologic cancer	2.11e-06	9.49e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3R1—hematologic cancer	2.09e-06	9.42e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTPN11—hematologic cancer	2.07e-06	9.32e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MAPK3—hematologic cancer	2.02e-06	9.08e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CREB1—hematologic cancer	2e-06	9.03e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BRAF—hematologic cancer	1.98e-06	8.92e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCL2—hematologic cancer	1.96e-06	8.84e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL6R—hematologic cancer	1.95e-06	8.81e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CREBBP—hematologic cancer	1.95e-06	8.8e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CB—hematologic cancer	1.93e-06	8.69e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAP2K1—hematologic cancer	1.86e-06	8.39e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CD—hematologic cancer	1.85e-06	8.34e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—KRAS—hematologic cancer	1.81e-06	8.16e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGF2—hematologic cancer	1.77e-06	7.98e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3R1—hematologic cancer	1.75e-06	7.87e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—JAK2—hematologic cancer	1.7e-06	7.65e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTEN—hematologic cancer	1.67e-06	7.51e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CA—hematologic cancer	1.66e-06	7.5e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MDM2—hematologic cancer	1.66e-06	7.47e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MTOR—hematologic cancer	1.61e-06	7.27e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CB—hematologic cancer	1.61e-06	7.27e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—EP300—hematologic cancer	1.59e-06	7.16e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HRAS—hematologic cancer	1.54e-06	6.94e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN1B—hematologic cancer	1.51e-06	6.82e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CASP3—hematologic cancer	1.48e-06	6.69e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL2—hematologic cancer	1.48e-06	6.68e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL6—hematologic cancer	1.47e-06	6.64e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCND1—hematologic cancer	1.44e-06	6.51e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—JUN—hematologic cancer	1.44e-06	6.49e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN1A—hematologic cancer	1.4e-06	6.3e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTEN—hematologic cancer	1.39e-06	6.28e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK8—hematologic cancer	1.36e-06	6.14e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT1—hematologic cancer	1.36e-06	6.13e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EP300—hematologic cancer	1.33e-06	5.99e-05	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MAPK3—hematologic cancer	1.3e-06	5.84e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SRC—hematologic cancer	1.29e-06	5.82e-05	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MYC—hematologic cancer	1.26e-06	5.68e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VEGFA—hematologic cancer	1.26e-06	5.67e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—STAT3—hematologic cancer	1.25e-06	5.62e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NRAS—hematologic cancer	1.24e-06	5.6e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK3—hematologic cancer	1.19e-06	5.37e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CA—hematologic cancer	1.18e-06	5.3e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MYC—hematologic cancer	1.16e-06	5.22e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TGFB1—hematologic cancer	1.16e-06	5.21e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KRAS—hematologic cancer	1.07e-06	4.82e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CA—hematologic cancer	9.83e-07	4.43e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKT1—hematologic cancer	9.61e-07	4.33e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TP53—hematologic cancer	9.51e-07	4.29e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HRAS—hematologic cancer	9.1e-07	4.1e-05	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AKT1—hematologic cancer	8.74e-07	3.94e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL6—hematologic cancer	8.71e-07	3.92e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT1—hematologic cancer	8.03e-07	3.62e-05	CbGpPWpGaD
